Search by tag «Anticancer drugs» 4 results
Chemists at ITMO University have designed an AI-based platform that identifies nanoparticles with selective cytotoxicity to cancer cells. According to the corresponding article in Small, the system should be expected to optimize particle synthesis and reduce the side effects of cancer treatment.
In collaboration, researchers from two Russian universities have developed compounds that trigger programmable death in cancer cells and tested their efficiency on cervical tumor samples. The new compounds do not affect healthy cells, their toxicity being eight times lower than that of doxorubicin, a commonly used cancer treatment. This means that in the future, treatments using the new compound may help avoid the common side effects of chemotherapy.
Flu Vaccine and Lung Cancer Medication Developed by ITMO Technopark’s Resident Awarded Gold Medals at the iENA 2019 Exhibition in Germany
The company ATG Service Gene, a resident of ITMO University’s Technopark, was awarded two gold medals at the international exhibition of ideas, inventions and innovations iENA 2019 that recently concluded in the German city of Nuremberg. Recognized were two inventions by the St. Petersburg scientists – an innovative flu vaccine and a medication that can help in combating lung cancer. ITMO.NEWS spoke to the company’s Director for Science Ilya Dukhovlinov to find out more about the award-winning drugs.
Last week, ITMO University’s international research center SCAMT hosted a lecture by the leading scientist in the field of anticancer drugs, Professor at the Department of Drug Discovery and Biomedical Sciences of the University of South Carolina (the US), Igor Roninson. Dr. Roninson spoke about the main pillars of creating new drugs and answered the topical question of why they take such a long time in developing. ITMO.NEWS put down the key points of the presentation.